Marianne A. Riise Bergsaker

Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway

Anneke Steens, Marianne A. Riise Bergsaker, Ingeborg S. Aaberge et al. · Vaccine · 2013 · 195 citations

Vaccination, Vaccine Safety, Invasive Pneumococcal Disease +7

Tracking parental attitudes on vaccination across European countries: The Vaccine Safety, Attitudes, Training and Communication Project (VACSATC)

Paweł Stefanoff, Svenn‐Erik Mamelund, Mary Robinson et al. · Vaccine · 2010 · 150 citations

Vaccinology, Vaccine Safety, Vaccination +13

Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program

Torbjørn Wisløff, Tore G. Abrahamsen, Marianne A. Riise Bergsaker et al. · Vaccine · 2006 · 64 citations

Vaccination, Vaccine Development, 7-Valent Pneumococcal Conjugate +6

Immunisation of migrants in EU/EEA countries: Policies and practices

Cristina Giambi, Martina Del Manso, G Marchetti et al. · Vaccine · 2019 · 53 citations · Full text

Persisting Immune Responses Indicating Long-Term Protection after Booster Dose with Meningococcal Group B Outer Membrane Vesicle Vaccine

Berit Feiring, J. E. Fuglesang, Philipp Oster et al. · Clinical and Vaccine Immunology · 2006 · 52 citations · Full text

Immunology, Immunodominance, Abstract Menbvac +18